laboratorybas
surveil
tool
establish
consist
minipool
test
nucleic
acid
prepar
limit
detect
copi
per
reaction
confid
interv
protocol
distribut
among
five
german
univers
hospit
j
u
r
n
l
p
r
e
p
r
f
approach
prove
principl
one
case
detect
minipool
abstract
background
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
emerg
china
late
subsequ
caus
pandem
surveil
import
better
appreci
evolv
pandem
longitudin
monitor
effect
public
health
measur
object
aim
provid
rapid
easi
establish
costeffect
laboratorybas
surveil
tool
studi
design
use
minipool
rna
prepar
nucleic
acid
extract
routin
respiratori
sampl
technic
valid
assay
distribut
protocol
within
inform
network
five
german
univers
laboratori
result
test
total
minipool
resembl
sampl
shortli
upsurg
case
germani
one
minipool
react
posit
resolut
one
individu
sampl
test
posit
sampl
hospit
patient
suspect
contract
conclus
approach
laboratorybas
surveil
use
minipool
prove
concept
easili
adapt
resourcesav
might
assist
public
health
laboratori
surveil
investig
formal
j
u
r
n
l
p
r
e
p
r
f
march
declar
pandem
earli
case
detect
crucial
contain
pandem
symptombas
case
definit
set
mani
countri
worldwid
howev
evid
transmiss
chain
initi
asymptomat
case
mildli
diseas
patient
case
miss
current
recommend
symptombas
case
definit
may
lead
unrecogn
local
spread
seen
itali
iran
recent
us
limit
pandem
aggress
public
health
respons
set
mani
countri
worldwid
howev
resurg
case
anticip
whenev
strict
public
health
isol
measur
lift
therefor
one
biggest
challeng
unresolv
issu
public
health
surveil
rapid
identif
time
epidem
peak
rapidli
identifi
unrecogn
case
hospit
effici
resourcesav
cost
effect
manner
propos
ad
hoc
laboratorybas
surveil
approach
base
upon
minipool
mp
test
nucleic
acid
prepar
respiratori
sampl
submit
laboratori
routin
diagnost
workflow
compris
individu
nucleic
acid
na
extract
respiratori
sampl
pool
extract
na
sampl
batch
specif
realtim
rtpcr
first
step
analyz
impact
minipool
mp
test
batch
sampl
per
pool
nucleic
acid
extract
respiratori
specimen
pharyng
swab
viral
transport
medium
sputum
bronchoalveolar
lavag
fluid
use
minelut
viru
kit
qiagen
hilden
germani
qiacub
system
recommend
elut
done
volum
set
mp
individu
na
prepar
combin
pool
dilut
factor
retriev
leftov
na
prepar
respiratori
sampl
repres
varieti
virus
local
biobank
freiburg
set
mp
test
four
mp
use
rtpcr
individu
patient
test
describ
exclud
possibl
unspecif
reaction
mp
procedur
mp
also
test
use
specif
realtim
rtpcr
describ
determin
analyt
sensit
mp
approach
use
vitrotranscrib
rna
standard
e
gene
obtain
european
viru
archiv
global
evag
http
wwweuropeanvirusarchivecom
e
gene
rtpcr
assay
describ
rtpcr
done
abi
instrument
appli
biosystem
weiterstadt
germani
spike
differ
vitrotranscrib
rna
concentr
store
na
prepar
respiratori
sampl
establish
mp
replic
test
done
determin
limit
detect
lod
describ
final
use
na
prepar
three
actual
case
freiburg
contain
copiesml
j
u
r
n
l
p
r
e
p
r
f
copiesml
copiesml
respect
set
three
mp
contain
one
posit
na
prepar
retest
sampl
distribut
workflow
within
inform
network
german
laboratori
tabl
site
tertiari
care
center
total
site
site
b
site
c
bed
site
site
e
respect
ethic
approv
studi
requir
sinc
activ
accord
legal
provis
defin
german
infect
protect
act
ifsg
sampl
submit
routin
patient
care
diagnost
written
inform
consent
obtain
patient
data
use
current
studi
anonym
prior
obtain
author
abl
detect
pathogen
mp
test
posit
individu
rtpcr
tabl
report
diagnost
workflow
laboratorybas
surveil
rapid
cost
effect
manner
shortli
identif
specif
realtim
rtpcr
protocol
set
distribut
worldwid
avail
rapid
reliabl
diagnost
earli
case
detect
instrument
outbreak
scenario
public
health
perspect
easi
establish
cost
effect
laboratorybas
screen
strategi
may
assist
rapid
case
detect
surveil
ultim
better
understand
epidem
technic
done
parallel
use
sampl
routin
diagnost
subsequ
test
rna
howev
circul
influenza
case
across
europ
merg
upsurg
mani
laboratori
may
lack
capac
resourc
perform
addit
singl
patient
sampl
test
addit
shortag
pcr
reagent
becom
issu
concern
huge
number
addit
molecular
test
perform
global
rel
short
period
time
minim
work
load
resourc
cost
pool
approach
nucleic
acid
extract
might
consid
use
assay
describ
corman
et
al
abl
demonstr
almost
exactli
j
u
r
n
l
p
r
e
p
r
f
higher
lod
due
mp
relat
dilut
factor
data
china
show
rna
concentr
rang
copi
per
millilit
give
rise
notion
mp
procedur
sensit
enough
clinic
sampl
anoth
studi
mildli
diseas
patient
show
averag
copi
per
swab
howev
moment
lack
comprehens
inform
viral
rna
concentr
mildli
diseas
asymptomat
case
critic
abl
detect
one
low
concentr
sampl
dilut
mp
close
lod
pool
procedur
network
paramount
effici
respons
emerg
infect
aim
provid
easi
implement
workflow
set
inform
network
abl
test
total
mp
cover
differ
geograph
region
germani
perspect
approach
set
rather
easili
e
g
public
health
laboratori
done
daili
basi
reduc
cost
compar
individu
patient
test
could
allow
longitudin
monitor
effect
contact
reduct
measur
popul
level
earli
detect
epidem
wave
light
evolv
epidem
possibl
unrecogn
spread
within
popul
propos
rapid
straightforward
screen
strategi
approach
prove
principl
might
assist
public
health
laboratori
europ
elsewher
rapidli
detect
case
might
otherwis
remain
undetect
sampl
submit
routin
patient
care
diagnost
ethic
approv
studi
requir
sinc
activ
accord
legal
provis
defin
german
infect
protect
act
ifsg
written
inform
consent
obtain
patient
data
use
current
studi
anonym
prior
obtain
author
compet
interest
author
conflict
interest
declar
